Sun Pharma Q4FY18E Result Expectation

Sun Pharma is expected to report weak numbers in Q4; commentary on the US business, especially the Halol plant, will be keenly observed.

from India Infoline News Service https://ift.tt/2KOtZ9U

Comments

Popular posts from this blog

What are the key measures of market volatility?